The purpose of the study is to evaluate the safety and efficacy pemvidutide on MASH resolution and MASH fibrosis.
If you are interested in enrolling in the clinical trial or would like more information, please click here to contact us.
CLINICAL TRIALS
PERFORMA TRIAL: Phase 3, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in Subjects with MASH
STATUS: Enrolling
For more informationIMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH)
STATUS: Completed
For more informationThe purpose of the study was to evaluate the safety and efficacy of pemvidutide on MASH resolution and MASH fibrosis.
For details on the IMPACT Phase 2b MASH trial results, click here.
RECLAIM STUDY: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects with Obesity or Overweight
STATUS: Active
For more informationThe purpose of the study was to evaluate the safety and efficacy of pemvidutide in the treatment of AUD in subjects with obesity or overweight.
For details on the RECLAIM Phase 2 AUD trial results, click here.
RESTORE TRIAL: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
STATUS: Active, not recruiting
For more informationThe purpose of the study is to assess the safety and efficacy of pemvidutide on liver disease due to excess alcohol consumption.
